Tuesday, August 16, 2022 | Back issues
Courthouse News Service Courthouse News Service

Shareholder Class Action

Shareholders challenge the $1.2 billion sale of Sucampo Pharmaceuticals to Mallinckrodt, for $18 a share, in a federal class action.

GREENBELT, Md. — Shareholders challenge the $1.2 billion sale of Sucampo Pharmaceuticals to Mallinckrodt, for $18 a share, in a federal class action.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.

Loading
Loading...